Sign in
Not yet recruitingNo phase

Following children with eosinophilic esophagitis over time and their quality of life

Follows children with eosinophilic esophagitis over 24 months, including their quality of life.

Key facts

Who runs it
Fondation Lenval
Where
France1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Outcome of Children With Eosinophilic Esophagitis
Status
Not yet recruiting
People taking part
16 people, planned
Started
Mar 2024
Expected to end
Dec 2028
Type of study
Interventional
Treatments tested
  • Digestive endoscopy
Record updated
16 January 2024

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for children with eosinophilic esophagitis who are about to start treatment. They will be followed for 24 months, including their quality of life.

Age
2 Years to 17 Years
Sex
All
Disease stage
Eosinophilic esophagitis, diagnosed by the criteria of the PNDS published in July 2022.
Earlier treatment
Children must be about to start treatment.

Main reasons for not taking part

  • No consent from one of the 2 parents or the legal guardian
  • Not covered by a social security scheme

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Diagnosis of OE according to the diagnostic criteria of the PNDS published in July 2022
  • Due to start treatment
  • informed consent from one of the 2 parents or the representative of parental authority
  • Membership of a social security scheme

Who cannot take part

  • -

The main criteria, as questions

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 2 and 17 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The investigator would like to create a prospective cohort of patients in order to describe eosinophilic esophagitis with the specificities corresponding to our geographical territory, and to study their evolution at 3 months, 6 months, 12 months, 18 months and 24 months.

Read full original descriptionShow less

This study would also enable us to investigate the quality of life of these chronically ill patients

The group in the trial

  • Management of eosinophilic esophagitisOther group

    Follow-up visits are always organized in the same way. A consultation with a gastropediatrician will take place, with assessment of symptoms (PEESS score) and quality of life (PedsQL module for eosinophilic esophagitis and PedsQL 4.0 Generic Core Scales). Then, if treatment needs to be introduced or changed, a digestive endoscopy with biopsies will be carried out at 3 months to determine whether the patient is in remission or not. Depending on the results, the patient may be advised to adapt or maintain the current treatment.

    Treatment: Digestive endoscopy

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Outcomes of Children With Eosinophilic Esophagitis: a Prospective Monocentric Observational Study
Plain-language title
Following children with eosinophilic esophagitis over time and their quality of lifeGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Criteria questions
Built from NCT06190080, who can take part
Record updated
16 January 2024